New grant will support clinical trial of wearable vital sign monitor
Jun 26, 2018
Drs. Michael McGillion and PJ Devereaux and their research team have received a FedDev Ontario Health Ecosphere grant and industry support for a clinical trial involving patients recovering after cardiac surgery.
What is the study about?
The study will test a new medical tracking tool called Vitaliti™, which is a wearable Continuous Vital Sign Monitor (CVSM) under development by Cloud DX of Kitchener, Ontario.
Using Vitaliti™, the research team will gather vital signs data on hundreds of post-operative patients at Hamilton Health Sciences, one of the project partners. Patients will wear the device for up to 30 days after their operations.
Why is this innovation needed?
The purpose of the innovation is to improve tracking of vital signs. Currently, health care providers depend on early warning scores to identify patients at risk of post-surgery complications. While these scores are helpful, they are a ‘one size fits all’ model, and can miss subtle signs in individual circumstances. The hope is that these devices will provide more detailed, patient-specific information, allowing health care providers to step in before patients get too sick.
If the device works well with cardiac patients, the developers, Cloud DX, plan to expand its testing to patients undergoing non-cardiac surgery as well.
The grant is supported by the Federal Economic Development Agency of Southern Ontario (FedDev Ontario).
McGillion is an Associate Professor in the McMaster School of Nursing. He holds the Heart and Stroke Foundation/Michael G. DeGroote Endowed Chair of Cardiovascular Nursing Research. His current research focuses on finding ways to prevent complications, infection and death in patients following cardiac surgery.
Details of grant:
McGillion M, Good A, Dvirnik N, Yang S, Marcucci M, Devereaux PJ. VERDICT: Vitaliti Verification and VISION 2 Pilot. FedDev Ontario Health Ecosphere grant. Budget Amount Total: $785,101 (FedDev: $300,000; Industry Support: $485,101). 2018 May – 2019 Mar.
SMArTVIEW research project